A prospective cohort study to explore predictive factors to TS-1 plus platinum-based drugs in patients with squamous cell lung cancer YCRG10
Latest Information Update: 06 Nov 2018
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Carboplatin; Cisplatin
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 29 Oct 2018 Status changed from recruiting to discontinued.
- 26 Apr 2013 New trial record